Literature DB >> 33807946

Urinary Microbiome Characteristics in Female Patients with Acute Uncomplicated Cystitis and Recurrent Cystitis.

Jeong-Ju Yoo1, Hee Bong Shin2, Ju Sun Song3, Minjung Kim3, Jina Yun1, Zisun Kim4, Yoo Min Lee5, Sang Wook Lee6, Kwang Woo Lee6, Woong Bin Kim6, Chang Beom Ryu1, Sung-Woo Park1, Seong Kyu Park1, Ho-Yeon Song7, Young Ho Kim6.   

Abstract

Traditionally, the diagnostic mainstay of recurrent urinary tract infection has been urinary culture. However, the causative uropathogen of recurrent cystitis has not been well established. Urine DNA next-generation sequencing (NGS) can provide additional information on these infections. Herein, we compared urine NGS results and urine cultures in patients with acute uncomplicated cystitis (AUC) and recurrent cystitis (RC), and evaluated the difference in microbiome patterns in the NGS results. Patients who underwent urine culture and NGS due to AUC or RC were retrospectively reviewed. All urine samples were collected via a transurethral catheter and studied utilizing a type of NGS called 16S ribosomal RNA gene amplification and sequencing. The sensitivity of urine NGS was significantly higher than that of conventional urine culture (69.0% vs. 16.7%, p < 0.05). The detection rate of urine NGS was slightly lower in the RC group than in the AUC group (67.7% vs. 72.7%). Microbiome diversity was significantly higher in the RC group compared to the AUC group (p = 0.007), and the microbiome composition was significantly different between the AUC and RC groups. In the urine NGS results, Pseudomonas, Acinetobacter, and Enterobacteriaceae were found in the AUC group, and Sphingomonas, Staphylococcus, Streptococcus, and Rothia spp. were detected in the RC group. Urine NGS can significantly increase the diagnostic sensitivity compared to traditional urine culture methods, especially in RC patients. AUC and RC patients had significant differences in bacterial diversity and patterns. Therefore, recurrent cystitis might be approached from a different perspective.

Entities:  

Keywords:  16S rRNA next-generation sequencing; cystitis; microbiome; urinary tract infection

Year:  2021        PMID: 33807946      PMCID: PMC7961880          DOI: 10.3390/jcm10051097

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  5 in total

1.  Differential Urinary Microbiota Composition Between Women With and Without Recurrent Urinary Tract Infection.

Authors:  Lei Huang; Xiangyan Li; Bo Zheng; Pengtao Li; Dali Wei; Chenwei Huang; Liying Sun; Haixia Li
Journal:  Front Microbiol       Date:  2022-05-26       Impact factor: 6.064

2.  Gardnerella vaginalis in Recurrent Urinary Tract Infection Is Associated with Dysbiosis of the Bladder Microbiome.

Authors:  Jeong-Ju Yoo; Ju Sun Song; Woong Bin Kim; Jina Yun; Hee Bong Shin; Mi-Ae Jang; Chang Beom Ryu; Sung Shin Kim; Jun Chul Chung; Jung Cheol Kuk; Eung Jin Shin; Ho-Yeon Song; Byung Chul Yu; Eek-Sung Lee; Seongho Ryu; Jae Heon Kim; Sung Soo Jung; Young Ho Kim
Journal:  J Clin Med       Date:  2022-04-20       Impact factor: 4.964

Review 3.  Recurrent Urinary Tract Infections and Asymptomatic Bacteriuria in Adults.

Authors:  David Hernández-Hernández; Bárbara Padilla-Fernández; María Yanira Ortega-González; David Manuel Castro-Díaz
Journal:  Curr Bladder Dysfunct Rep       Date:  2021-12-01

Review 4.  Molecular Diagnostic Methods Versus Conventional Urine Culture for Diagnosis and Treatment of Urinary Tract Infection: A Systematic Review and Meta-analysis.

Authors:  Alec Szlachta-McGinn; K Marie Douglass; Un Young Rebecca Chung; Nicholas James Jackson; J Curtis Nickel; A Lenore Ackerman
Journal:  Eur Urol Open Sci       Date:  2022-09-02

5.  The detection of urinary viruses is associated with aggravated symptoms and altered bacteriome in female with overactive bladder.

Authors:  Qi Sun; Leqian Li; Hao Zhou; Ying Wu; Yubo Gao; Bingyi Wu; Yifeng Qiu; Zhipeng Zhou; Qixiang Song; Jie Zhao; Peng Wu
Journal:  Front Microbiol       Date:  2022-09-23       Impact factor: 6.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.